References
- GomezMValleVArosFSanzGSalaJFiolMOxidized LDL, lipoprotein (a) and other emergent risk factors in acute myocardial infarction (FORTIAM study)Rev Esp Cardiol200962437338219401122
- NarukoTUedaMEharaSItohAHazeKShiraiNPersistent high levels of plasma oxidized low-densty lipoprotein after acute myocardial infarction predict stent restenosisArterioscler Thromb Vasc Biol200626487788316469945
- MeisingerCBaumertJKhuseyinovaNLoewelHKoenigWPlasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general populationCirculation2005112565165716043640
- YamashitaHEharaSYoshiyamaMNarukoTHazeKShiraiNElevated plasma levels of oxidized low-density lipoprotein relate to the presence of angiographically detected complex and thrombotic coronary artery lesion morphology in patients with unstable anginaCirc J200771568168717456991
- PentikainenMOOorniKAla-KorpelaMKovanenPTModified LDL – trigger of atherosclerosis and inflammation in the arterial intimaJ Internal Med2000247335937010762453
- SteinbrecherUPWitztumJLParthasarathySSteinbergDDecrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolismArterioscler Thromb Vasc Biol198772135143
- GrunfeldCDelaneyJAWankeCPreclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM studyAIDS200923141841184919455012
- HavlirDVGetahunHSanneINunnPOpportunities and challenges for HIV care in overlapping HIV and TB epidemicsJAMA2008300442343018647985
- DenekeSMFanburgBLRegulation of cellular glutathioneAm J Physiol19892574 Pt 1L163L1732572174
- GriffithOWBiologic and pharmacologic regulation of mammalian glutathione synthesisFree Radic Biol Med19999–1092293510569625
- WitztumJLSteinbergDRole of oxidized low density lipoprotein in atherogenesisJ Clin Invest1991886178517921752940
- RosenblatMVolkovaNColemanRAviramMAnti-oxidant and anti-atherogenic properties of liposomal glutathione: studies in vitro, and in the atherosclerotic apolipoprotein E-deficient miceAtherosclerosis20071952e61e6817588583
- FimognariFLScarlataSConteMEIncalziRAMechanisms of atherothrombosis in chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis200831899618488431
- CollesSMMaxsonJMCarlsonSGChisolmGMOxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterolsTrends Cardiovasc Med2001113–413113811686002
- BerlinerJATerritoMCSevanianARaminSKimJABamshadBMinimally modified low density lipoprotein stimulates monocyte endothelial interactionsJ Clin Invest1990854126012662318980
- ThomasEDRambergRESaleGESparkesRSGoldeDWDirect evidence for a bone marrow origin of the alveolar macrophage in manScience1976192424310161018775638
- ClineMJLehrerRITerritoMCGoldeDWUCLA Conference. Monocytes and macrophages: functions and diseasesAnn Intern Med19788817888339803
- PingXDHarrisFLBrownLAGauthierTWIn vivo dysfunction of the term alveolar macrophage after in utero ethanol exposureAlcohol Clin Exp Res200731230831617250624
- DengTZhangLGeYLuMZhengXRedistribution of intracellular calcium and its effect on apoptosis in macrophages: Induction by oxidized LDLBiomed Pharmacother200863426727418602792
- QiaoMKisgatiMCholewaJMZhuWSmartEJSulistioMSIncreased expression of glutathione reductase in macrophages decreases atherosclerotic lesion formation in low-density lipoprotein receptor-deficient miceArterioscler Thromb Vasc Biol20072761375138217363688
- HamilosDLZelarneyPMascaliJJLymphocyte proliferation in glutathione-depleted lymphocytes: direct relationship between glutathione availability and the proliferative responseImmunopharmacology19891832232352575086
- MessinaJPLawrenceDACell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phaseJ Immunol19891436197419812789253
- CantinAMNorthSLHubbardRCCrystalRGNormal alveolar epithelial lining fluid contains high levels of glutathioneJ Appl Physiol19876311521573040659
- BrownLASPingX-DHarrisFLGauthierTWGlutathione availability modulates alveolar macrophage function in the chronic ethanol-fed ratAm J Physiol Lung Cell Mol Physiol20072924L824L83217122355
- StockerRKeaneyJFJrRole of oxidative modifications in atherosclerosisPhysiol Rev20048441381147815383655
- HanselTTBarnesPJRecent Advances in the Pathophysiology of COPDBasel Boston Birkhäuser Verlag2004
- RahmanIMacNeeWOxidative stress and regulation of glutathione in lung inflammationEur Respir J200016353455411028671
- BarnesPJOxidative stress in COPDHanselTTBarnesPJRecent Advances in the Pathophysiology of COPDBasel; BostonBirkhäuser Verlag2004
- LoebGASkeltonDCCoatesTDFormanHJRole of selenium-dependent glutathione peroxidase in antioxidant defenses in rat alveolar macrophagesExp Lung Res198814 Suppl9219363208729
- PietarinenPRaivioKDevlinRBCrapoJDChangLYKinnulaVLCatalase and glutathione reductase protection of human alveolar macrophages during oxidant exposure in vitroAm J Respir Cell Mol Biol19951344344417546773
- ZhangWSalomonRGOxidized phospholipids, isolevuglandins, and atherosclerosisMol Nutr Food Res200549111050106216270278
- WintergerstESJelkJRahnerCAsmisRApoptosis induced by oxidized low density lipoprotein in human monocyte-derived macrophages involves CD36 and activation of caspase-3Eur J Biochem2000267196050605910998066
- WangYQiaoMMieyalJJAsmisLMAsmisRMolecular mechanism of glutathione-mediated protection from oxidized low-density lipoprotein-induced cell injury in human macrophages: role of glutathione reductase and glutaredoxinFree Radic Biol Med200641577578516895798
- PedersenNCHoEBrownMLYamamotoJKIsolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndromeScience19872357907933643650
- VenketaramanVRodgersTLinnaresRTuberculosis immunity in healthy and HIV-infected subjectsAIDS Res Ther200631516504020
- BuhlRJaffeHAHolroydKJSystemic glutathione deficiency in symptom-free HIV-seropositive individualsLancet19892129412982574255
- de QuayBMalinverniRLauterburgBHGlutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteineAIDS199268158191418777
- EckHPGmunderHHartmannMPetzoldtDDanielVDrogeWLow concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patientsBiol Chem Hoppe Seyler19893701011082784973
- HelblingBvon OverbeckJLauterburgBHDecreased release of glutathione into the systemic circulation of patients with HIV infectionEur J Clin Invest19962638448682153
- PantaleoGGraziosiCFauciASNew concepts in the immunopathogenesis of human immuno deficiency infectionN Engl J Med19933283273358093551
- LevyJAHIV pathogenesis and long term survivalAIDS19937140114108280406
- DrogeWHolmERole of cysteine and glutathione in HIV infection and other diseases associated with muscle wasting and immunological dysfunctionFASEB J199711107710899367343
- HerzenbergLAde RosaSCDubsJGGlutathione deficiency is associated with impaired survival in HIV diseaseProc Natl Acad Sci U S A199794196719729050888
- StaalFJGlutathione and HIV infection: reduced reduced or increased oxidized?Eur J Clin Invest199821941969568464
- TsaoTCHongJLiLFHsiehMJLiaoSKChangKSImbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosisChest200011710310910631206
- HagAMKristoffersenUSPedersenSFRegional gene expression of LOX-1, VCAM-1, and ICAM-1 in aorta of HIV-1 transgenic ratsPloS One20094e817019997643
- DayaramYKTalaueMTConnellNDVenketaramanVCharacterization of a glutathione metabolic mutant of Mycobacterium tuberculosis and its resistance to glutathione and nitrosoglutathioneJ Bacteriol200618841364137216452418
- BrillKJLiQLarkinRHuman natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanismsInfect Immun20016931755176511179353
- ChanEDChanJSchlugerNWWhat is the role of nitric oxide in murine and human host defense against tuberculosis? Current knowledgeAm J Respir Cell Mol Biol200125560661211713103
- FlynnJLChanJTrieboldKJDaltonDKStewartTABloomBRAn essential role for interferon-α in resistance to Mycobacterium tuberculosis infectionJ Exp Med1993178224922527504064
- VenketaramanVDayaramYKAminAGRole of glutathione in macrophage control of mycobacteriaInfect Immun20037141864187112654802
- VenketaramanVDayaramYKTalaueMTConnellNDGlutathione and nitrosoglutathione in macrophage defense against M. tuberculosisInfect Immun20057331886189415731094
- MillmanACSalmanMDayaramYKConnellNDVenketaramanVNatural killer cells, glutathione, cytokines and innate immunity against Mycobacterium tuberculosisJ Interferon Cytokine Res20082811318370866
- VenketaramanVMillmanACSalmanMGlutathione levels and immune responses in tuberculosis patientsMicrob Pathog20084425526117959342
- GutteridgeJMLipid peroxidation and antioxidants as biomarkers of tissue damageClin Chem19954112 Pt 2181918287497639
- Schulze-OsthoffKLosMBaeuerlePARedox signalling by transcription factors NF-kappa B and AP-1 in lymphocytesBiochem Pharmacol1995507357417575632
- DubeySSSinhaKKGuptaJPVitamin C status, glutathione and histamine in gastric carcinoma, tuberculous enteritis and non-specific ulcerative colitisIndian J Physiol Pharmacol19852921111144093192
- KwiatkowskaSPiaseckaGZiebaMPiotrowskiWNowakDIncreased serum concentrations of conjugated diens and malondialdehyde in patients with pulmonary tuberculosisRespir Med199993427227610464892
- JackCIJacksonMJHindCRCirculating markers of free radical activity in patients with pulmonary tuberculosisTuber Lung Dis19947521321378032046
- TsaoTCHongJLiLFHsiehMJLiaoSKChangKSImbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosisChest2000117110310910631206
- MakonkawkeyoonSLimson PobreRNMoreiraALSchaufVKaplanGThalidomide inhibits the replication of human immunodeficiency virus type 1Proc Natl Acad Sci U S A199390597459788327469
- WallisRSNsubugaPOkweraAPentoxifylline in human immunodeficiency virus-seropositive tuberculosis: a randomized, controlled trialJ Infect Dis199617447277338843209
- Mayanja-KizzaHJones-LopezEOkweraAUganda-Case Western Research Collaboration. Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in UgandaJ Infect Dis2005191685686515717259
- WallisRSKalayjianRJacobsonJMA study of the immunology, virology, and safety of prednisone in HIV-1-infected subjects with CD4 cell counts of 200 to 700 mm(−3)J Acquir Immune Defic Syndr200332328128612626887
- van CrevelROttenhoffTHvan der MeerJWInnate immunity to Mycobacterium tuberculosisClin Microbiol Rev200215229430911932234
- ChristmanMA2ndGoetzDJDickersonEWnt5a is expressed in murine and human atherosclerotic lesionsJ Physiol Heart Circ Physiol20082946H2864H2870